You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Marburg Virus Prophylactic Medical Countermeasure
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terrible morbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditional vaccines have contributed greatly to public health, they have some limitations especially in the context of operati ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Detecting Substandard, Nonconforming, Improperly Processed and Counterfeit Materiel
SBC: Ocean Bay Information and Systems Management, LLC Topic: DLA15C001Inspecting for and detecting counterfeit, unapproved material substitutions or substandard processed raw material using existing processes is difficult, time consuming and expensive.Ocean Bay, LLC and the Primary Investigator, Karen Bruer, formed a team consisting of Ocean Bay, LLC, Savanah River National Laboratory and Old Dominion University, to apply for DLA15C-001:Detecting Substandard, Noncon ...
STTR Phase II 2017 Department of DefenseDefense Logistics Agency -
Marburg Virus Prophylactic Medical Countermeasure
SBC: Flow Pharma, Inc. Topic: CBD18A002Through this STTR contract, we propose to evaluate the efficacy of our vaccine, FlowVax Marburg, in nonhuman primates (NHPs). This will be achieved through four Tasks. In Task 1, we will manufacture the vaccine in a quantity sufficient for the animal studies. In Task 2, we will perform MHC genotyping on a representative population of NHPs and, based on results, select a set of MHC-matched NHPs for ...
STTR Phase II 2020 Department of DefenseOffice for Chemical and Biological Defense -
Eye-readable Solution-based Dye Displacement Probe for Large-area Detection of Opioids
SBC: INTELLIGENT OPTICAL SYSTEMS, INC. Topic: CBD20AT001Intelligent Optical Systems, Inc., in collaboration with Bowling Green State University, proposes to develop a field-rugged, eye-readable indicating spray solution that can immediately detect synthetic opioids over a large area of contamination (i.e., military vehicles, individual protective equipment, clandestine labs, etc.). The proposed chemosensor in a spray solution format will detect multipl ...
STTR Phase I 2021 Department of DefenseOffice for Chemical and Biological Defense -
Marburg Virus Prophylactic Medical Countermeasure
SBC: MAPP BIOPHARMACEUTICAL, INC. Topic: CBD18A002There are currently no vaccines or therapeutics available for Marburg Virus Disease (MVD). Given the specter of weaponization and the terriblemorbidity and high mortality rate of MVD, this represents a critical threat to the operational readiness of the Warfighter. While traditionalvaccines have proven to be a huge contribution to public health, they do have some limitations especially in the cont ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense -
Detecting Substandard, Nonconforming, Improperly Processed and Counterfeit Materiel
SBC: Ocean Bay Information and Systems Management, LLC Topic: DLA15C001"Micro-calorimetry is a Nondestructive Test (NDT) capable of detecting heat characteristics that could identify improperly processed, counterfeit, substandard, nonconforming or fake raw material prior to materials introduction into end-product production cycles. Current calorimetric technology is an extremely sensitive, expensive and time consuming process, utilizing an adiabatic or semi-adiabat ...
STTR Phase I 2016 Department of DefenseDefense Logistics Agency -
Marburg Virus Prophylactic Medical Countermeasure
SBC: Flow Pharma, Inc. Topic: CBD18A002Flow Pharma, Inc. is a biotechnology company in the San Francisco Bay Area developing fully synthetic cytotoxic T lymphocyte (CTL)stimulating peptide vaccines for Marburg virus. The FlowVax vaccine platform allows us to create dry powder formulations of biodegradablemicrospheres and TLR adjuvants incorporating class I and class II T cell epitopes. FlowVax vaccines can be designed for delivery by i ...
STTR Phase I 2018 Department of DefenseOffice for Chemical and Biological Defense